MedPath

AI-Driven Prediction of Dialysis Outcome With EHR

Recruiting
Conditions
Dialysis Patients
Registration Number
NCT06791447
Lead Sponsor
The Eye Hospital of Wenzhou Medical University
Brief Summary

This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for outcome of dialysis patients, leveraging multimodal health data.

Detailed Description

This study aims to develop an AI-assisted model to predict clinical outcomes in dialysis patients, focusing on both primary outcomes (e.g., mortality) and intermediate outcomes (e.g., anemia, blood pressure, nutritional status, and calcium-phosphate metabolism). The study will utilize patients' EHR data, including laboratory test results, medical history, dialysis treatment information, and clinical observations, to predict these health outcomes. The goal is to improve early identification of at-risk patients, enabling better clinical decision-making and personalized care strategies.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000000
Inclusion Criteria
  1. Patients who have been undergoing dialysis (either hemodialysis or peritoneal dialysis) for at least 3 months.
  2. Complete and accessible EHR data, including medical history, laboratory test results, dialysis treatment details, and clinical observations.
  3. Participants must provide informed consent for the use of their health data for research purposes.
Exclusion Criteria
  1. Patients with incomplete or missing critical EHR data, including medical history, laboratory results, dialysis data, or treatment details necessary for the study.
  2. Patients who have been on dialysis for less than 3 months, to ensure stable data for outcome prediction.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality Prediction Accuracy1 year

The ability of the AI-assisted predictive model to accurately predict the risk of mortality in dialysis patients. Prediction accuracy will be assessed using the Area Under the Curve (AUC), F1 score, and sensitivity/specificity. The model will be evaluated by comparing the predicted mortality risk with actual outcomes (i.e., whether patients survived or passed away during the study period).

Secondary Outcome Measures
NameTimeMethod
Complications Prediction Accuracy1 year

The accuracy of the AI-assisted predictive model in forecasting complications commonly experienced by dialysis patients, including anemia, uncontrolled blood pressure, poor nutritional status, and abnormalities in calcium-phosphate metabolism. The model's performance will be assessed using metrics such as AUC, F1 score, and accuracy by comparing predicted values to actual clinical outcomes, such as lab results, clinical diagnoses, and patient health status.

Trial Locations

Locations (1)

General Hospital of PLA

🇨🇳

Beijing, Beijing, China

General Hospital of PLA
🇨🇳Beijing, Beijing, China
Delong Zhao
Contact
+86 13810512704
feiliu0108@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.